InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,495.52
(
0.45%
)
US TECH 100
18,346.40
(
0.00%
)
Dow Jones
40,736.96
(
-0.23%
)
Brent Oil
70.13
(
0.86%
)
Bitcoin
56,598.83
(
-1.86%
)
Post# of 253078
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

lgonber

Send PM Follow Ignore
Followers 12
Posts 648
Boards Moderated 0
Alias Born 12/20/2014

lgonber

Re: biocqr post# 185332

Thursday, 01/01/2015 2:45:22 PM

Thursday, January 01, 2015 2:45:22 PM

Post# of 253078
Agree with the article in ACHN potencial, and adding value to BMY or ABBV un getting better combos ( cheaper and por lower weeks of treatments)
On the other side, I believe RGLS drug will never reach the market. I dont see the subcutaneus injection if by the time there will be a crowded market with oral drugs
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up